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1 Introduction
2A and ‘2A-like’ oligopeptide (20–30aa) sequences
(‘2As’) are widely used in biotechnology and bio-
medicine to co-express multiple different proteins
within the same cell. Genes encoding proteins are
linked  via 2A sequences to form a single ORF.
Translation of the single ORF results, however, in
the biosynthesis of each protein as a discrete trans-
lation product [1–10]. The great utility here is that
multiple proteins comprising heteromultimers, ma-
cromolecular assemblies, biochemical pathways,
etc., plus (selectable) marker proteins may be as-
sembled into, and co-expressed from, a single
transgene. Since 2As function in all eukaryotic sys-
tems tested to date, they have found utility in ani-
mal, plant and microbial biotechnologies (http://
www.st-andrews.ac.uk/ryanlab/Index.htm and re-
viewed in [11, 12]). Notably, this system has recent-
ly been used in adoptive cell therapies (ACT)
[13–18], genetic engineering of human stem cells
[19–21] and the co-expression of transcription fac-
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tors in the induction of pluripotent stem cells
[22–27].
2As are neither proteolytic elements nor sub-
strates for cellular proteinases, but mediate a new-
ly discovered form of translational recoding event
referred-to variously as ribosome ‘skipping’,‘stop-
go’ and ‘stop-carry on’ translation [5, 8, 9].When a
ribosome encounters 2A within an ORF it ‘skips’
the synthesis of the glycyl–prolyl peptide bond at
the C-terminus of 2A. The nascent protein is re-
leased from the ribosome by eukaryotic release (ter-
mination) factors 1 and 3 (eRF1, eRF3), 2A forming
its C-terminus [9]. The ribosome then resumes
translation of the downstream sequences. As one
test of our intra-ribosomal, co-translational, model
for the mechanism of the 2A reaction, we assem-
bled complementary DNA (cDNA) encoding a syn-
thetic polyprotein comprising a protein targeted to
the exocytic pathway (prepro-αfactor; αF), 2A, and
green fluorescent protein (GFP). Expression in
yeast showed that the translation product up-
stream of 2A was,indeed,targeted to the endoplas-
mic reticulum (ER) whilst the downstream product
localised to the cytosol. The 2A reaction occurred
even though the nascent protein was ‘shielded’
from cytosolic proteinases by the establishment of
a ribosome:translocon complex [7].
To extend the utility of 2A in the co-expression of
proteins targeted to different sub-cellular compart-
ments,we constructed plasmids encoding a panel of
polyproteins similar to those used in our yeast
analyses. Our ‘basic’ polyprotein construct com-
prised enhanced yellow fluorescent protein (EYFP),
2A, enhanced cyan fluorescent protein (ECFP), a
second 2A and puromycin resistance (PAC; plasmid
pPDF20).All proteins were co-expressed and locat-
ed to the cytoplasm [28]. This construct was modi-
fied by the insertion of a GalT type II signal-anchor
sequence (β-1,4 galactosyltransferase, GT) onto the
N-terminus, to encode a [GT-EYFP-2A-ECFP-2A-
PAC] polyprotein (plasmid pPDF18). When ana-
lysed using translation systems in vitro the expected
translation profile was observed: high-level ‘cleav-
age’ (>90%) at both of the 2As, producing the major
translation products [GT-EYFP-2A], [ECFP-2A]
and PAC.When this construct was used to transfect
HeLa cells, however, whilst the fluorescence signal
from EYFP (correctly) localised in the Golgi,the sig-
nal from ECFP localised to the ER [28]. The latter
was unexpected since [ECFP-2A] did not bear a sig-
nal sequence. Furthermore, this result was at vari-
ance with our findings in yeast, where the protein
downstream of 2A localised to the cytosol and was
also at variance with reports in the literature where
secreted heterodimers were co-expressed using 2A
(discussed below).
Our conclusion from the data derived from the
fluorescent proteins bearing N-terminal co-trans-
lational signal sequences (types I and II) was that
(i) translation of the first protein (bearing a signal
sequence) lead to the formation of the ribo-
some:translocon (Sec61) complex,(ii) the N-termi-
nal protein was translocated into the ER and (iii)
that the protein downstream of 2A (no signal se-
quence) simply ‘slipstreamed’ through the pore of
the translocon complex already formed [28].
Here we present data that shows this interpre-
tation to be incorrect.We show that an interaction
between the C-terminal region of certain nascent
peptides and the translocon complex can affect the
structure of the C-terminus of 2A within the pep-
tidyl-transferase centre of the ribosome.This leads
to inhibition of the 2A reaction, greatly increasing
peptide bond formation and the production of ‘un-
cleaved’ fusion proteins.The fluorescence patterns
we observed were primarily due, therefore, to the
localisation and, to some extent, the fluorescent
properties of these uncleaved forms.
2 Materials and methods
2.1 Cloning
Plasmids pPDF18, pPDF19, pPDF20 and pPDF67
were as described previously [28].Plasmids encod-
ing the fluorescent proteins EYFP and ECFP and
the GT signal were purchased from Clontech.The
intermediate plasmid pPDF15 [GT-EYFP-2A-PAC]
was derived from pPDF9 [GFP-2A-PAC] [28], the
GFP removed with NheI/XbaI and replaced with
GT-ECFP amplified from pECFP-Golgi (Clontech)
using the primers PDFK (5′-CAGATCCGCTAGC
ATGAGGCTTCGGGAG-3′) and 3′egfp/XbaI (5′-
GGCCTCTAGAC TTGTACAGCTCGTCCAT-3′).The
ECFP was then removed by restriction with
BamHI/XbaI and replaced with the PCR product
EYFP (restricted with BglII and XbaI) from
pEYFP-C1 (Clontech) using the primers PDFN (5′-
GGCAGCAGATCTGGCTAGCATGAGGGTGAGC
AAGGGCGAG-3′) and 3′egfp/XbaI.To obtain plas-
mid pPDF45ΔB the 2A-GT-ECFP ‘cassette’ was
first removed from pPDF19 by XbaI restriction
then ligated into pTG394pac [29] doubly restricted
with XbaI and SpeI. The 3′pac-2A-GT-ECFP por-
tion of the insert was then removed by BglII
restriction, blunt-ended (Klenow fill-in) and re-
stricted with SacII. The restriction fragment was
then ligated into pPDF15 restricted with XhoI,
blunt-ended (Klenow fill-in) and SacII to produce
plasmid pPDF41 (encodes [GT-EYFP-2A-PAC-2A-
GT-ECFP]).Finally,restrictions with ApaI followed© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 215
by BamHI removed the pac-2A and GT sequences,
respectively.
Yeast signal sequences were amplified as αF-2A
and DNαF-2A fragments from plasmids ppαF-2A-
GFP and DNαF-2A-GFP [7] using the primers JN1
(5′-CCAGCTAGCGAATTCGTCGACCTCGAG-3′)
and JN2 (5′-AAAACCATGGGCCCAGGGTTGG-3′)
[7]. The PCR products were restricted with
NheI/ApaI and used to replace the GT-EYFP-2A of
pPDF45, similarly restricted. The yeast signals
were removed from these plasmids with NheI/XbaI
and used to replace the GT signal-anchor sequence
excised from pPDF45ΔB with NheI/NheI, to give
pPDF90 [DNαF-EYFP-2A-ECFP] and pPDF91
[αF-EYFP-2A-ECFP],respectively.pPDF45ΔB was
restricted with NheI and XbaI to remove the EYFP
and form plasmid pPDF87. To obtain pGL1,
pPDF45ΔB was doubly restricted with SpeI and
XbaI to remove the 3′ end of the cytomegalovirus
(CMV) promoter, the T7 promoter, the GT signal
and EYFP .This sequence was replaced with a sim-
ilar fragment (with the shorter 5′ end of EYFP),
produced by PCR amplification of pPDF15 using
primers PDFY (5′-GACAATTGCATGAAGAATC-
3′) and PDFX.30 (5′-CTCGCCTCTAGAGCTGAAC
TTGTGGCCGTTTAC-3′), similarly restricted.
pPDF45ΔB was restricted with BspEI/XbaI to re-
move EYFP , and replaced with a 3′ deleted version
of the gene generated by PCR using plasmid
pPDF15 as the template and oligonucleotides T7
(5′-TAATACGACTCACTATAGGG-3′) and PDFX.180
(5′-GTAGTGTCTAGAGAGCTGCACGCTGCCGT
CCTC-3′) to form pAN1.9.Fortuitously,this reverse
primer also hybridised 120 nucleotides down-
stream to give us an additional in-frame deleted
version of the EYFP gene (pAN1.1)
Deletions in the EYFP gene in plasmid pPDF67
were introduced by replacing the BglII/BsrGI re-
striction fragment (containing CMV/T7 promoters,
GT signal and EYFP) with equivalent fragments
(having 3′ deleted versions of EYFP) from pGL1 to
obtain pPDF107 and from pPDF87 to obtain pGL3.
Plasmid pGL11 was obtained from pPDF67 by
deleting the full EYFP gene, plus 2A, with
BstXI/BamHI and the insertion of a small PCR
fragment of EYFP , plus 2A (amplified using
primers PDFX.30b; 5′-TGGAGTCCAAGGATCTG
GCTCACAACGTCTATATCATGGC-3′ and SEQ4;
5′-ACCATGGTGGCGACCGGTGG AT-3′),similarly
restricted, recreating the EYFP-2A junction pres-
ent in pPDF116. Plasmid pPDF67 was restricted
with BstXI and SgrAI to delete EYFP ,which was re-
placed with the equivalent fragment from pAN1.9,
or pAN1.1,to obtain pPDF115 or pPDF116,respec-
tively. Progressively smaller 3′ deletions in EYFP
were introduced in pPDF67 restricted with BstXI
and SgrAI.The deleted EYFP sequences were gen-
erated from PCR of pPDF15 by using the primers
T7 and PDFX.200 (5′-CAGGGCCACCGGTGCGCA
TGCTCTAGAGTTGTCGGGCAGCAGCACGGGG
CCG-3′) producing pPDF117 or using primers T7
and PDFX.220 (5′-GCGGCCACCGGTGCGCATGC
TCTAGACATGTGATCGCGCTTCTCGTTGGG-
3′), to produce pPDF118.
2.2 In vitro translation
Coupled transcription/translation assays were per-
formed using rabbit reticulocyte lysates (Promega)
as described [7].
2.3 Cell culture, transfection and imaging
HeLa cells were grown in DMEM supplemented
with 10% foetal calf serum. HeLa cells were seeded,
transfected with Genejuice (Novagen),subsequent-
ly fixed (24 h),and imaged using DeltaVision micro-
scope system (Applied Precision) as described [28].
2.4 Immunofluorescence
Transfected cells were fixed and then incubated
with primary antibodies,either;(i) rabbit polyclon-
al anti-2A (kind gift of Dr D.Vignali) or (ii) mouse
monoclonal anti-V5 (kind gift of Prof. R. Randall).
Texas red goat anti-rabbit and Texas red goat anti-
mouse (Molecular Probes) were used as secondary
antibodies.
2.5 Western blotting
HeLa cells were transfected and lysates collected
48 h later. Samples were run in 10 or 12.5% SDS–
PAGE gels,transferred to Immobilon-P membranes
(Millipore). Membranes were probed with primary
antibodies, either (i) mouse monoclonal anti-GFP
(Roche), (ii) anti-V5 or (iii) anti-2A antibodies. Sec-
ondary antibodies used were ECL anti-mouse IgG-
Peroxidase from sheep (GE Healthcare) and anti-
rabbit IgG-Peroxidase from goat (Sigma). Mem-
branes were developed using ECL Plus Western
Blotting Detection System (GE Healthcare).
3 Results
3.1 Sub-cellular localisation
To simplify certain plasmid constructions and to
more closely mimic those constructs analysed in
yeast [7], the [2A-PAC] portion of the pPDF18
polyprotein was deleted to create plasmid
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pPDF45ΔB, encoding [GT-EYFP-2A-ECFP] (Fig.
1A). Transfection of HeLa cells with pPDF45ΔB
produced the same pattern of fluorescence as that
obtained with pPDF18: yellow fluorescence in the
Golgi and cyan fluorescence in the ER (Fig. 1B).
When the GT type II signal-anchor in pPDF45ΔB
was replaced by a type I signal sequence from the
ER luminal protein calreticulin, both fluorescence
signals were located in the ER (data not shown).
We suspected that the difference between the
observations made in yeast and mammalian cells
could lie either in;(i) some peculiarity of the signal
sequences used in these analyses or (ii) the nature
of the sequences upstream of 2A. To address the
first possibility we replaced the GT Golgi targeting
sequence with either of the two signal sequences
used in the yeast experiments (αF and Dap2p –
DNαF), obtaining plasmids pPDF90 (encoding
[DNαF-EYFP-2A-ECFP]) and pPDF91 (encoding
[αF-EYFP-2A-ECFP]). The yeast αF signal se-
quence has been shown to function within mam-
malian cells [30, 31]. Transfection of HeLa cells
with these plasmids resulted in a similar pattern of
fluorescence: both yellow and cyan signals in the
ER.Again, it appeared that in both cases ECFP ap-
parently ‘slipstream’ translocated into the ER (Fig.
1B).This effect was not,therefore,due to the nature
of the signal sequences.
To address the second possibility we analysed a
panel of deletions within EYFP . In this, and in all
subsequent cases below, the numerals given in
plasmid designations indicates the residues pres-
ent in the EYFP deletion forms. The 2A sequence
used in these analyses was derived from plasmid
pSTA1/34 [6]. Following the 2A reaction the up-
stream protein bears, therefore, a C-terminal (2A)
extension of 23aa. Initially we deleted all EYFP
sequences, creating plasmid pPDF87 (encodes
[GT-2A-ECFP];Fig.2A).We followed the fate of the
[GT-2A] protein using an anti-2A mAb (kind gift of
Dr.Dario A.Vignali).Whilst this antibody recognis-
es 2A C-terminal extension of proteins, it does not
recognise 2A within uncleaved fusion proteins (Fig.
1C). Transfection of HeLa cells with plasmid
pPDF87 resulted in [GT-2A] localising to the Golgi
and ER, with ECFP diffused throughout the cyto-
plasm but, inexplicably, the vast majority localising
to the nucleus (Fig. 2B). Whilst the protein up-
stream of 2A ([GT-2A]) had entered the exocytic
pathway as expected, the protein downstream had
not. We wished to confirm ECFP had not entered
the exocytic pathway by intensifying the fluores-
cence signal from ECFP by targeting the protein to
the nucleus.A modified construct, pGL3, encoding
[GT-2A-ECFP-N-PAC] (Fig. 3A) was expressed in
HeLa cells.As before,[GT-2A] localised to the Gol-
gi, whilst [ECFP-N-PAC] predominantly localised
to the nucleus. In addition, a clear, but weak, signal
could now be observed within the ER (Fig. 3B).
Figure 1. Cleavage activities and sub-cellular localisation of products de-
rived from 2A-containing polyproteins. N-terminal signal sequences (stip-
pled, boxed, areas) were derived from either GT, yeast α factor (αF) or the
yeast Dap2p signal sequence (DNαF). Single ORFs were assembled to
comprise; (i) an N-terminal signal sequence (GT – pPDF45ΔB; DNαF –
pPDF90; αF – pPDF91), (ii) a fluorescent protein marker (EYFP; open
boxed area), (iii) 2A (shaded, boxed, area) and (iv) a second fluorescent
protein marker (ECFP; open boxed area) (panel A). In all cases protein ex-
pression was driven by a CMV promoter in the plasmid backbone. HeLa
cells were transfected with plasmid constructs and images taken 24 h later
(scale bar = 10 μm). The GT N-terminal signal-anchor directed EYFP to
the Golgi and ECFP to the ER. This was also the case for proteins contain-
ing N-terminal yeast signal sequences (panel B). Cell lysates were pre-
pared 24 h post-transfection, proteins separated by SDS–PAGE and sub-
sequently analysed by Western blotting using antibody probes as indicat-
ed (panel C). Rabbit reticulocyte coupled transcription/ translation in vitro
systems were programmed with plasmid cDNA constructs, as indicated.
The incorporation of 35S-methionine into proteins synthesised de novo was
determined by SDS–PAGE and phosphorimaging (panel D).© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 217
To further alter the sequence context immedi-
ately upstream of 2A, a range of deletions were
made in the C-terminal region of EYFP . Plasmids
pGL1 and pPDF107 both encode the same small
fragment of the N-terminus of EYFP between the
GT signal and the 2A. When either construct was
transfected in HeLa cells, the ECFP (or, in the case
of pPDF107 [ECFP-N-PAC]) apparently ‘slip-
streamed’ in the ER (as with pPDF45ΔB),while the
[GT-ΔEYFP1-30-2A] localised to the Golgi (Figs. 2A,
B and 3A, B). In both cases a substantial amount of
the full-length translation product was observed –
the 2A reaction was inhibited (see below).Interest-
ingly, when this N-terminal region of EYFP was
also deleted (pPDF87, Fig. 2A; pGL3, Fig. 3A), the
2A reaction was no longer inhibited (see below)
and the vast majority of the protein downstream of
2A was not translocated into the ER (Figs. 2B, 3B).
Plasmid pAN1.9 encodes EYFP with a much
smaller deletion at the C-terminus ([GT-ΔEYFP 1-140-
2A-ECFP]; Fig. 2A). Here, the result obtained was
similar to that using pPDF87: while the [GT-
ΔEYFP 1-140-2A] product upstream of 2A localised to
the Golgi,the downstream product (ECFP) localised
to the cytoplasm and nucleus (Fig. 2B). A similar
plasmid, pPDF115, encodes [GT-ΔEYFP1-140-2A-
ECFP-N-PAC] (Figs. 3 and 4A). Transfection with
this plasmid showed the protein [GT-ΔEYFP1-140-
2A] upstream of 2A had,again,entered the exocyt-
ic pathway.Although bearing a GT signal, this pro-
tein was distributed in both the ER and Golgi.The
protein downstream of 2A (ΔECFP-N-PAC]) was
localised in the nucleus,with a much weaker signal
from the ER (Figs. 3 and 4B).
If the context immediately upstream of 2A is
crucial in producing this apparent slipstream
translocation, then small deletions in the C-termi-
nal region of EYFP might be sufficient to reduce or
eliminate this effect. A series of constructs were
made with progressive deletions within EYFP
(plasmids pPDF118, pPDF117, pPDF116 and
pPDF115; Fig. 4A). In all cases, the protein up-
stream of 2A was translocated into the ER and the
downstream [ECFP-N-PAC] localised to the nucle-
us (with a weak signal in the ER).The data from all
of these plasmids contrasts with the ER localisation
of [ECFP-N-PAC] in cases when the C-terminal re-
gion of EYFP was present immediately upstream of
2A (plasmid pPDF67; Figs. 3 and 4B). Deletion of
just the C-terminal 20aa of EYFP (pPFD118) re-
lieved the inhibition of the 2A reaction.
3.2 Effect of the upstream context on the 2A
reaction in vitro and in vivo
We routinely monitor the cleavage activity of 2A-
containing artificial polyproteins using coupled
transcription/translation rabbit reticulocyte cell-
Biotechnol. J. 2010, 5, 213–223 www.biotechnology-journal.com
Figure 2. Effect of deletion of sequences upstream of 2A. EYPF sequences
upstream of 2A were deleted (panel A). The number of residues between
the end of the transmembrane domain of the GT signal sequence and the 
N-terminal residue of 2A are shown above the appropriate images in pan-
el B. HeLa cells were transfected with plasmid constructs and images
taken 24 h later (scale bar = 10 μm). The localisation of EYFP and ECFP
was determined by their native fluorescence, whilst the localisation of the
deletion forms of EYFP was determined using anti-2A antibodies (panel
B). Cell lysates were prepared, separated by SDS–PAGE and subsequently
Western blotted using anti-GFP antibodies (panel C). In vitro translation
systems programmed with constructs as indicated and the incorporation
of 35S-methionine determined by SDS–PAGE and phosphorimaging.
The translation products are denoted as; 1 = [GT-EYFP-2A-ECFP],
2 = [GT-ΔEYFP-2A-ECFP], 3 = [GT-EYFP-2A] and 4 = [ECFP] (panel D).
Note: the [GT-ΔEYFP-2A] products from pAN1.9/pGL1 and the [GT-2A]
product from pPDF87 were too small to be resolved in this gel system.
Lanes in PAGE analyses of proteins (panels C and D) were derived from
constructs used to produce the cell images shown in panel B, above.Biotechnology
Journal
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free translation systems (Figs. 1–4, panel D). Using
constructs encoding artificial polyproteins such as
[EYFP-2A-ECFP] we had correlated the activities
we had observed using in vitro translation systems
with that observed within transfected cells (ana-
lysed by Western blotting). In both cases cleavage
was high – indeed higher (almost 100%) in vivo.W e
took it, therefore, that the in vitro analyses were a
good indication of cleavage in vivo.
When we investigated the cleavage in vivo of the
polyproteins we had created that gave rise to the
apparent slipstream sub-cellular localisation –
Figure 4. Effects of deletion of sequences immediately upstream of 2A. A
panel of constructs were assembled with a nested set of deletions up-
stream of 2A. As described above, the ECFP bore a nuclear localisation sig-
nal (panel A). The number of residues between the end of the trans-
membrane domain of the GT signal sequence and the N-terminal residue
of 2A are shown above the appropriate images in panel B. Cell lysates
were prepared, separated by SDS–PAGE and subsequently Western blot-
ted using anti-GFP antibodies. Rabbit reticulocyte in vitro translation
systems were programmed with constructs as indicated and the incorpo-
ration of 35S-methionine determined by SDS–PAGE and phosphorimag-
ing. Translation products are denoted as; 1 = [GT-EYFP-2A-ECFP-N-PAC],
2 = [GT-ΔEYFP-2A-ECFP-N-PAC], 3 = [ECFP-N-PAC], 4 = [GT-EYFP-2A] and
5 = [GT-ΔEYFP-2A]. Note: the higher molecular masses of the [GT-ΔEYFP-
2A] products allowed complete resolution in this gel system. The ‘extra’
bands arise from internal initiation events in this batch of reticulocyte
lysate. Lanes in PAGE analyses of proteins (panels C and D) were derived
from constructs used to produce the cell images shown in panel B, above.
Figure 3. Effect of inclusion of a nuclear localisation signal. To visualise
the partitioning of ECFP between the cytoplasm and the ER, we included a
nuclear localisation signal (N; together with PAC) such that any cytoplas-
mic [ECFP-N-PAC] would be localised in the nucleus (panel A). The num-
ber of residues between the end of the transmembrane domain of the GT
signal sequence and the N-terminal residue of 2A are shown above the ap-
propriate images in panel B. HeLa cells were transfected with plasmid
constructs and images taken 24 h later (scale bar = 10 μm). The localisa-
tion of EYFP and ECFP was determined by their native fluorescence, whilst
the localisation of the deletion forms of EYFP was determined using anti-
2A antibodies (panel B). Cell lysates were prepared, separated by
SDS–PAGE and subsequently Western blotted using anti-GFP antibodies
(panel C). Rabbit reticulocyte in vitro translation systems were pro-
grammed with constructs as indicated and the incorporation of 35S-me-
thionine determined by SDS–PAGE and phosphorimaging. Translation
products are denoted as; 1 = [GT-EYFP-2A-ECFP-N-PAC], 2 = [GT-ΔEYFP-
2A-ECFP-N-PAC] and 3 = [ECFP-N-PAC]. Note: the gel system we used 
was designed to resolve the [GT-ΔEYFP-2A-ECFP-N-PAC]/[GT-EYFP-2A-
ECFP-N-PAC] products from [ECFP-N-PAC], and the [GT-ΔEYFP-2A] prod-
ucts from pPDF115/pPDF107/pGL1. The [GT-2A] product from pGL3
were not resolved in this system. Lanes in PAGE analyses of proteins
(panels C and D) were derived from constructs used to produce the cell
images shown in panel B, above.© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 219
Both chains bore their native signal sequences and
active IL-12 was secreted into the media [32]. Sim-
ilarly, the heavy and light chains of antibodies
cleaved highly efficiently, were assembled and se-
creted [33].The α- and β-subunits of the T-cell re-
ceptor (in both orientations) cleaved highly effi-
ciently,assembled and were localised to the plasma
membrane [13]. Human iduronidase alpha-L
(IDUA) was targeted to the secretory pathway
whilst a marker protein downstream of 2A (Disco-
soma spred fluorescent protein, DsRed2) localised
to the cytosol [34].
In our previous study with fluorescent polypro-
teins where the first protein was targeted to the se-
cretory pathway and the protein downstream of 2A
was cytosolic, we attributed the unexpected ER
sub-cellular distribution of the downstream pro-
tein to slipstream translocation [28].Here we show
a complete correlation between those polyproteins
displaying the apparent slipstream effect and those
with low levels of the 2A reaction in vivo – moni-
tored by Western blotting.A large proportion of the
translation products are uncleaved, leading to
translocation of the fusion protein into the exocyt-
ic pathway.
Analyses of protein targeting using a control
construct (pPDF93), encoding [GT-EYFP-ECFP],
showed that (i) the fusion protein partitions be-
tween the Golgi and ER (mainly ER) and (ii) both
proteins fluoresce in both compartments – produc-
ing complete co-localisation upon merging the im-
ages [28]. However, when 2A is present between
the fluorescent proteins (pPDF45ΔB), whilst the
fusion protein partitions between the Golgi and
ER, the [GT-EYFP-2A] product formed by the 2A
reaction (strongly fluorescent) localises to the Gol-
gi, whilst we assume the [ECFP] product (much
more weakly fluorescent than EYFP) is diffused
throughout the cytoplasm and nucleus and not de-
tectable.
In the case of constructs with N-terminal signal
sequences,the source of the inhibitory effect of the
EYFP C-terminal sequences (immediately up-
stream of 2A) must lie in the interaction with the
translocon complex, since they cleave highly effi-
ciently using in vitro translation systems. For ex-
ample, the [GT-EYFP-2A-ECFP-N-PAC] polypro-
tein encoded by pPDF67 shows high level of cleav-
age in vitro, while in vivo most of the protein de-
tected by anti-GFP antibodies was in the
full-length, uncleaved, form [GT-EYFP-2A-ECFP-
N-PAC], with very little detected as the cleavage
products [GT-EYFP-2A] and [ECFP-N-PAC] (Figs.
3, 4 panels C, D).
We have proposed that nascent 2A forms an
α-helix with a tight-turn at its C-terminus. The
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those bearing N-terminal signal sequences – we
found a very different picture. For example, in the
case of pPDF45ΔB and pPDF67,translation in vitro
produced only a small amount of the full-length
translation product (Figs. 2–4, panel D), whilst ex-
pression in vivo showed this form to be the major
product with the ‘cleaved’ forms being weak bands
– sometimes visible only with prolonged exposure
(Figs.2–4,panel C).The in vivo analyses of cleavage
showed a major difference in efficiency between
those constructs which gave rise to the apparent
‘slipstream’ effect and those which did not. The
slipstream effect showed complete correlation with
low efficiency of the 2A reaction – evidenced by the
levels of the full-length translation products (Figs.
1–4, panel D).Taken together these results strong-
ly suggest that in the case of proteins targeted to
the exocytic pathway the immediate upstream
context of 2A may strongly influence the efficiency
of the reaction. In the case of pGL1 and pPDF107
the same number of residues lie between the end
of the transmembrane domain of the GT signal
sequence and the N-terminal residue of 2A
(Figs.2A and 3A,respectively).We designed pGL11
([GT-ΔEYFP 150-180-2A-ECFP-N-PAC]) to encode the
same number of residues between the GT signal
and 2A as in pGL1/pPDF107, but in pGL11 the up-
stream context for 2A is identical to that in
pPDF116 – a construct that showed a highly effi-
cient 2A reaction (Fig. 4C). Upon transfection of
cells with plasmid pGL11, the translation product
upstream of 2A ([GT-ΔEYFP150-180-2A]) was detect-
ed in the Golgi (immunofluorescence using anti-2A
antibodies) whilst the translation product down-
stream of 2A ([ECFP-N-PAC]) was localised pre-
dominantly in the nucleus. The 2A reaction was
highly efficient (using in vitro translation systems
and in vivo; Figs. 3C, D). These data are consistent
with the notion that, in the case of proteins enter-
ing the exocytic pathway, the context immediately
upstream of 2A may strongly inhibit the 2A reac-
tion.
4 Discussion
2A and 2A-like sequences are now widely used as
a tool for co-expression in biomedicine and
biotechnology due to (i) their shortness (20–30aa),
(ii) highly efficient cleavage, (iii) the uniform stoi-
chiometry of the cleavage products and (iv) their
activity in all eukaryotic cell-types tested to date.
Many laboratories have successfully used 2As to
co-express proteins targeted to the exocytic path-
way. For example, the p35 and p40 chains of inter-
leukin-12 (IL-12) were cleaved highly efficiently.Biotechnology
Journal
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helical portion is proposed to interact with the
ribosome exit tunnel such that the C-terminal por-
tion is sterically constrained within the peptidyl-
transferase centre of the ribosome [4, 5].The ester
linkage between 2A and transfer RNA (tRNA)gly is
precluded from nucleophilic attack by the prolyl-
tRNA in the A site, effectively ‘jamming’ trans-
lation.We have recently shown that this block is re-
lieved by the action of translation release factors 1
and 3 [9].
Residues that influence the 2A-mediated cleav-
age of cytosolic proteins map to within 30aa of the
cleavage site. This is consistent with many pro-
teinase protection studies which have shown the
length of nascent peptide within the ribosome exit
tunnel to be 30–40aa (Fig. 5; reviewed in [35]).The
eukaryotic ribosome exit tunnel is ∼100 Å long and
has an average diameter of ∼20 Å [36].
The C-terminal 20aa of EYFP upstream of 2A
that inhibited the 2A reaction are 28–48aa distal
from the peptidyl-transferase centre – since we
know that the C-terminus of 2A (23aa long + 4aa
linker) is in the P site when cleavage occurs (Fig.5).
Disulphide bond formation, photochemical cross-
linking,proteinase protection,glycosylation accep-
tor site and protein folding studies performed upon
nascent proteins transiting into the lumen of the
ER show that 65–70aa are present within the ribo-
some:translocon complex [37–42] (Fig. 5).The con-
sensus arising from structural studies on Sec61 or
Sec61/ribosome complexes is that the protein con-
ducting channel is formed at the interface of an
oligomeric assembly – probably a tetramer – of the
Sec61α,γ,β complex. The channel is co-axial with
the ribosome exit tunnel and is thought to be some
48–60 Å long [43–48].
Theoretical work suggests that nascent proteins
adopt an α-helical conformation [49] stabilised by
the exit tunnel [50]: indeed, dynamic simulations
suggested 2A adopted such a conformation [4].
Taken together,these data suggest that at the stage
in elongation when cleavage occurs (the C-termi-
nal glycyl-tRNAgly of 2A in the P site of the ribo-
some peptidyl-transferase centre), the C-terminal
20aa of the protein upstream (EYFP) most proba-
bly lie within a region defined by the interface be-
tween the ribosome and Sec61 complex and the
translocon tunnel itself (Fig. 5). Interactions be-
tween the nascent protein and the translocon tun-
nel may affect the conformation of 2A within the ri-
bosome exit tunnel and,in consequence,the C-ter-
minal tight-turn of 2A in the peptidyl-transferase
centre itself – inhibiting the 2A reaction.
The problem we have identified in the co-ex-
pression of certain proteins targeted to the exocyt-
ic pathway has significance for the biotechnologi-
cal utilities of 2A.The LOCATE sub-cellular locali-
sation database indicates that of all human pro-
teins currently analysed, ∼40% are either secreted
from the cell,located within the lumen/membranes
of cytoplasmic vesicular structures (excluding
mitochondria), or are plasma membrane proteins
(http://locate.imb.uq.edu.au/). Given that such a
high proportion of cellular proteins are initially
translocated into the ER, the ability to co-express
multiple proteins targeted to such sites is essential.
In this study we identified two regions of EYFP
which,when placed immediately upstream of 2A,in-
hibited the 2A reaction; (i) the C-terminal region
(residues 220–240: pPDF118) and (ii) the N-termi-
nal region (residues 1–29: pGL1/pPDF107). How-
ever, in constructs we assembled designed to co-
express influenza haemagglutinin (HA) or neu-
raminidase (NA) linked via 2A to fluorescent pro-
teins ([HA-2A-CherryFP] or [NA-2A-CherryFP]),
we observed the same effects we describe here:
very high-level cleavage using translation systems
in vitro, whilst expression in vivo showed the fluo-
rescent proteins localised in the ER and not to the
cytoplasm – again, the apparent slipstream effect.
This inhibition of the 2A reaction may be over-
come in two ways. Firstly, by the use of longer ver-
sions of 2A which incorporate a 39aa tract from the
C-terminus of protein 1D,immediately upstream of
2A in the FMDV polyprotein [6]. This extension
does not interact with the translocon pore to affect
the activity of 2A in the ribosome – effectively ‘in-
sulating’ the 2A sequence from the upstream pro-
tein.A number of studies suggest that cleavage ef-
Figure 5. Position of 2A and sequences immediately upstream in the
ribosome:translocon complex. In the case of polyproteins bearing an 
N-terminal signal sequence, the 2A oligopeptide (white ovals) and the
sequences immediately upstream (grey ovals) are predicted to be located
within the ribosome exit tunnel and translocon pore, respectively. The
lengths of the exit tunnel and translocon pore, plus the lengths of pep-
tides (amino acids) which may be accommodated [44–49] are also shown.© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 221
ficiency may be improved by using a flexible
Gly–Ser–Gly or Ser–Gly–Ser–Gly linker sequence
separating the upstream protein from the 2A se-
quence [51–53]. Recent work by Yang et al. (2008)
combined a furin cleavage site and a V5 oligopep-
tide spacer sequence immediately upstream of 2A
[54]. Furin is a proteinase enriched in the Golgi,
with a canonical recognition site of -R-X-↓(R/K)-R-.
For proteins targeted to, or transiting through, the
Golgi, incorporation of this site results in proteoly-
sis.This strategy may provide an excellent solution
since it removes the extended 2A linker [55]. We
have used a linker comprising the furin proteinase
cleavage site, 39aa of 1D, plus 2A (derived from
plasmid pSTA1/31; [6]) to overcome this problem.
In our influenza HA/NA co-expression studies the
use of this linker resulted in the correct localisation
of the cherry fluorescent protein to the cytoplasm,
and not the exocytic pathway (S.Vater, pers.comm.).
The second solution lies in the basic design – the
“gene” order – of the polyprotein. Previously de-
scribed 2A-based multigene vectors have revealed
the 2A region functions properly within different
contexts, but the cleavage efficiency varies as
flanking context changes.By swapping the order of
proteins in several artificial polyproteins the stoi-
chiometry was affected by the gene upstream of 2A
[56, 57]. If a problematic secreted/membrane pro-
tein is identified,then this could be incorporated as
the C-terminal component of the polyprotein sys-
tem.It should be noted in this context that in mam-
malian and yeast cells an N-terminal proline (such
as that produced by 2A-mediated cleavage) confers
a long half-life (>20 h) on proteins (http://www.
expasy.ch/tools/protparam-doc.html).
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